Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-05

Clinical Trial Update: Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing golimumab plus methotrexate to methotrexate alone in MTX-naïve psoriatic arthritis; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Golimumab (golimumab)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Instituto de Medicina Molecular João Lobo Antunes | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-05